MORGAN STANLEY PLC/CALL/INTUITIVE SURGICAL/580/0.01/20.06.25 Stock

Warrant

DE000ME8L7C1

Market Closed - Börse Stuttgart 12:52:24 2024-07-16 pm EDT
0.154 EUR -1.91% Intraday chart for MORGAN STANLEY PLC/CALL/INTUITIVE SURGICAL/580/0.01/20.06.25
Current month-13.48%
1 month+10.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 0.154 -1.91%
24-07-15 0.157 -2.48%
24-07-12 0.161 -8.00%
24-07-11 0.175 +6.71%
24-07-10 0.164 -2.38%

Delayed Quote Börse Stuttgart

Last update July 16, 2024 at 12:52 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
Issuer Morgan Stanley
WKN ME8L7C
ISINDE000ME8L7C1
Date issued 2024-02-12
Strike 580 $
Maturity 2025-06-20 (339 Days)
Parity 100 : 1
Emission price 0.17
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.199
Lowest since issue 0.079
Spread 0.006
Spread %3.64%

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
437.2 USD
Average target price
440.6 USD
Spread / Average Target
+0.77%
Consensus